FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and can find application in therapy aiming at stimulation of osseous and cartilaginous tissue growth by activation of pachymeninx, periosteum and endosteum ensured by hypotension application. The group of inventions involves a method for osteogenic and chondrogenic activation in a tissue area, a method of treating an osseous or cartilaginous injury and a composition for treating the osseous or cartilaginous injury containing a hypotension apparatus and a biocompatible frame.
EFFECT: use of the given group of inventions provides higher effectiveness of neogenesis ensured by stimulation of osseous and cartilaginous activity, healing and infiltration of the biological frame used.
42 cl, 11 dwg, 1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING CONTRACTURES IN ARTICULATIONS WITH DEGENERATIVE ALTERATIONS | 2002 |
|
RU2235518C2 |
METHOD FOR SURGICAL MANAGEMENT OF CRANIAL VAULT DEFECTS | 2018 |
|
RU2706501C1 |
METHOD OF PRODUCING TISSUE-ENGINEERED PERIOSTEUM FROM CELL SPHEROIDS FOR REPAIRING BONE DEFECTS OF SUBJECT | 2022 |
|
RU2819284C2 |
MULTI-DIMENSIONAL BIOMATERIAL AND METHOD FOR PREPARING IT | 2010 |
|
RU2542430C2 |
CONTOUR PLASTY METHOD AND IMPLANT FOR RESTORING, CORRECTING AND REMOVING OR SUBSTITUTING DEFECTS, INJURIES OR DEFORMITIES OF BONE OR CARTILAGE TISSUE | 2002 |
|
RU2218895C1 |
METHOD FOR PRODUCING MINERALIZED COMPOSITE MICROSCAFFOLDS FOR BONE TISSUE REGENERATION | 2016 |
|
RU2660558C2 |
METHOD OF COMPENSATION OF JOINT CARTILAGE DEFECTS | 2008 |
|
RU2383310C1 |
METHOD FOR PRODUCING TISSUE-ENGINEERED PERIOSTEUM FROM CELL SPHEROIDS FOR REPAIRING BONE DEFECTS IN PATIENTS | 2023 |
|
RU2818176C1 |
BONE FORMATION | 2016 |
|
RU2727241C2 |
METHOD FOR PRODUCTION OF BIOCOMPOSITE SPHEROIDS FOR BONE RESTORATION | 2020 |
|
RU2747087C1 |
Authors
Dates
2012-04-20—Published
2008-06-26—Filed